In the “Year in Review” program, McDermott Will & Emery partners will discuss and analyze the major developments and changes in patent law during 2013 and the key cases to watch in 2014. Our discussion will include:
The Supreme Court of the United States’ decisions in Gunn v. Minton, Bowman v. Monsanto Co., Federal Trade Commission v. Actavis, Inc. and AMP, et al. v. Myriad Genetics, Inc., et al.
The U.S. Court of Appeals for the Federal Circuit’s decisions impacting divided infringement, preliminary injunctions, patent exhaustion, abbreviated new drug application (ANDA) standards of review, intervening rights, claim construction, developments in the law of secondary considerations of non-obviousness and much more
Issues pending review by the U.S. Supreme Court
Practical and case law implications of the continued implementation of the America Invents Act, including trends and statistics for inter partes review and post-grant review
Who Should Attend:
Corporate IP Professionals
Corporate Licensing Executives
In-House Counsel
Business Development Professionals
Technology Transfer Professionals
Attorneys
Consultants
Academics
Students
Seminar Information
Date Presented:
April 09, 2014 1:00 PM Eastern
Length:
1 hour, 30 minutes
Registration Fee:
Free
Licensing Executives Society (USA & Canada)
CLE (California): 1.50
CLE (Illinois): 1.50
Certified Licensing Professionals, Inc.: 1.50
Products
Streaming
LES Member Price:$0.00
Cookies are small pieces of information that are stored by your browser on your computer’s hard drive.
This website uses cookies to enhance the convenience and use of the site, and has placed cookies already.
You can delete or block cookies within your browser settings.
Should you opt to do this, some parts of our site may not work.
By using this site, you agree to our use of cookies.
For more information, including instructions on how to remove the cookies that have been placed,
see our Privacy Policy.
